Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Ribological GmbH
Link has been incorrect on 2015-01-02

Ribological, based in Mainz, Germany, is a subsidiary of BioNTech AG. Ribological develops pharmacologically optimised, RNA-based drugs for targeted immunotherapy for cancer. The Group parent, BioNTech, is a spin-off from Johannes Gutenberg University, Mainz. Together with its subsidiaries, the company researches and develops molecular diagnostics and targeted immunotherapies for personalised clinical application. *


Period Start 2009-01-01 established
Period End 2014-03-06 renamed
  Group BioNTech (Group)
  Today BioNTech RNA Pharmaceuticals GmbH
  Successor BioNTech RNA Pharmaceuticals GmbH
Products Industry BIOTECH
  Industry 2 RNAi drug (RNAi therapeutic)
Persons Person Kring, Michael Maximilian (High Tech Corporate Services GmbH 201402 Managing Director + interim CFO/CEO others)
  Person 2 Sahin, Ugur (BioNTech 201207 Managing Director BioNTech + Ribological GmbH)
Region Region Mainz
  Country Germany
  Street 8 Hölderlinstr.
  City 55131 Mainz
  Tel +49-6131-576270-0
    Address record changed: 2020-12-02
Basic data Employees B: 11 to 50 (2011-12-25)
    * Document for �About Section�: 
Record changed: 2017-04-01


Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

More documents for BioNTech (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top